Five Young Minds in CNS Awards will be made in the following categories:
- Bipolar Disorder/Mania
- Depression and Anxiety
- Migraine
- Schizophrenia
- Stroke (acute)
The Awards Program achieved great success in 2001, “Applications to the 2001 Awards were of exceptional quality and I am very pleased to be able to support this career-enhancing initiative.” commented Professor Hans-Christoph Diener, Essen University, Germany and a member of the Award Steering Committee. “The Awards Program is a fantastic opportunity to assist today’s leading young physicians in reaching the pinnacle of their careers and I would urge all suitable candidates to apply.”
Those wishing to apply are required to submit a proposal demonstrating their academic promise and how winning an Award will assist them in the advancement of their career. The proposals can cover a wide range of activities including: innovative research, educational efforts, travel, and materials. The decision of each award winner is made by an independent steering committee of distinguished experts in their field.
Further information about the Awards, including an on-line submission form, can be accessed at http://www.astrazeneca.com/youngminds
AstraZeneca PLC is engaged in the research, development, manufacture and marketing of ethical (prescription) pharmaceuticals. It is one of the top five pharmaceutical companies in the world with leading positions in sales of gastrointestinal, oncology, anaesthesia including pain management, cardiovascular, central nervous system (CNS) and respiratory products.
In CNS, AstraZeneca is dedicated to providing medicines which have the potential to change patients lives. The company already markets ZOMIG® the leading second generation triptan and SEROQUEL® the fastest growing global antipsychotic. The exciting R&D pipeline includes leading approaches for the treatment of depression/anxiety disorders, overactive bladder disorders, dementia and stroke.
For further information, please contact:
Leslie Wheeler, AstraZeneca
Tel: +44 1625 519790
Mobile: +44 7802 871218
Email: leslie.wheeler@astrazeneca.com
Antonia Betts or Rebecca Moan, Shire Hall International
Tel. +44 (0) 207 471 1500
Email: antonia.betts@sh-international.com
Email: rebecca.moan@sh-international.com